Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02508961
Other study ID # 15/WS/0030
Secondary ID
Status Completed
Phase N/A
First received July 23, 2015
Last updated May 30, 2017
Start date January 2015
Est. completion date December 2016

Study information

Verified date May 2017
Source University of Glasgow
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study will be a pragmatic, single blind, randomised, controlled feasibility study, comparing 6 months of web-based physiotherapy plus usual care with usual care alone in pwMS. The study will recruit 90 pwMS from three UK Centres (30 from each centre); NHS Ayrshire and Arran, NHS Lothian, and Plymouth Hospitals NHS Trust.

The aim of this study is to assess the feasibility of a randomised controlled trial examining the effectiveness of a six-month web-based physiotherapy programme and usual care compared to usual care alone, in people moderately affected by MS and to gather essential information for the planning of a definitive trial, which would evaluate both clinical and cost effectiveness of the intervention.


Description:

Following baseline assessments, both groups will be given an appointment with the physiotherapist to agree shared goals and to devise an individualised exercise programme based upon their needs and treatment goals. Participants will then be randomised to one of two groups.

Participants randomised to the intervention group will receive their individualised exercise programme delivered via the web-based physio website. Participants will be asked to complete their exercise programme at least twice weekly. They will receive weekly standardised phone calls from the physiotherapist for the first two weeks of the programme. Every two weeks thereafter for the remainder of the 6 month intervention period the physiotherapist will review the exercise diary of each participant and remotely alter the participant's exercise programme as appropriate, by changing any combination of exercises, level of difficulty or number of repetitions. The number and type of exercises within the programme and duration to complete the exercise programme will be documented. Participants will be informed of any changes by standardised email.

Participants randomised to the control group will receive a print out exercise sheet of their individualised exercise programme. Participants will be asked to complete their exercise programme at least twice weekly. Compliance will be captured using a home exercise diary. Participants will also receive a weekly phone call from the physiotherapist for the first two weeks to check on progress.


Recruitment information / eligibility

Status Completed
Enrollment 90
Est. completion date December 2016
Est. primary completion date December 2016
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- A confirmed diagnosis of MS

- Known to a MS consultant in NHS Ayrshire and Arran, Lothian or Plymouth Hospitals NHS Trust

- EDSS of 4 - 6.5

- Access to a personal computer/tablet or smart television with an email address and internet connection

Exclusion Criteria:

- Currently taking part in regular exercise (two or more times per week) and/or a regular physiotherapy programme

- Poor cognitive function as assessed by a Mini Mental State Examination Score (MMSE) <24

- Any significant change in medication (within the last 3 months)

- Relapse within 3 months requiring treatment

- Other significant co-morbidities for which exercise is contra-indicated

- Unwilling to be randomised to intervention/control group

- Currently participating in another clinical trial (rehabilitation or pharmacological)

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Exercise
web-based physio exercise programme

Locations

Country Name City State
United Kingdom Anne Rowling Regenerative Neurology Clinic Edinburgh
United Kingdom Douglas Grant Rehabilitation Centre Irvine
United Kingdom University of Plymouth Plymouth

Sponsors (5)

Lead Sponsor Collaborator
University of Glasgow National Heatlh Service Ayrshire and Arran, NHS Lothian, Plymouth Hospitals NHS Trust, University of Plymouth

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Compliance to the exercise programme Number of completed exercise diary entries 9 months
Primary Two Minute Walk Test 9 months
Secondary Timed 25 Foot Walk 9 months
Secondary Timed Up and Go 9 months
Secondary Berg Balance Scale 9 months
Secondary Physical Activity Measured using the activPAL physical activity monitor 9 months
Secondary MS-Related Symptom Checklist 9 months
Secondary Multiple Sclerosis Impact Scale 9 months
Secondary Hospital Anxiety and Depression Scale 9 months
Secondary Health related quality of life EQ-5D 9 months
See also
  Status Clinical Trial Phase
Completed NCT05528666 - Risk Perception in Multiple Sclerosis
Completed NCT03608527 - Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis N/A
Recruiting NCT05532943 - Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis Phase 1/Phase 2
Completed NCT02486640 - Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
Completed NCT01324232 - Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis Phase 2
Completed NCT04546698 - 5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
Active, not recruiting NCT04380220 - Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
Completed NCT02835677 - Integrating Caregiver Support Into MS Care N/A
Completed NCT03686826 - Feasibility and Reliability of Multimodal Evoked Potentials
Recruiting NCT05964829 - Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis N/A
Withdrawn NCT06021561 - Orofacial Pain in Multiple Sclerosis
Completed NCT03653585 - Cortical Lesions in Patients With Multiple Sclerosis
Recruiting NCT04798651 - Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis N/A
Active, not recruiting NCT05054140 - Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis Phase 2
Completed NCT05447143 - Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis N/A
Recruiting NCT06195644 - Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients Phase 1
Completed NCT04147052 - iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis N/A
Completed NCT03594357 - Cognitive Functions in Patients With Multiple Sclerosis
Completed NCT03591809 - Combined Exercise Training in Patients With Multiple Sclerosis N/A
Completed NCT02845635 - MS Mosaic: A Longitudinal Research Study on Multiple Sclerosis